Nicola Milanesi
University of Florence
Internal medicinePatch testSurgeryDermatologySystemic therapyAllergic contact dermatitisDermatology Life Quality IndexTeledermatologyContact dermatitisAtopic dermatitisDiseaseMEDLINEAlitretinoinDupilumabPopulationChronic hand eczemaCoronavirus disease 2019 (COVID-19)Disease severityTreatment interruptionRefractoryMedicinePandemic
40Publications
6H-index
89Citations
Publications 41
Newest
#1Nicola Milanesi (UniFI: University of Florence)H-Index: 6
#2Massimo Gola (UniFI: University of Florence)H-Index: 13
Last. Filomena Russo (UNISI: University of Siena)H-Index: 2
view all 8 authors...
BACKGROUND Sleep disturbances are common in patients with atopic dermatitis (AD). Considering their relevant burden on health, routine screening of sleep disturbances seems to be very useful in AD adults management. However, few studies have evaluated the association between sleep disturbances and AD in adults and real-life data are lacking. The aim is to assess the effect of treatment with dupilumab on sleep disturbances in adult patients with severe atopic dermatitis. METHODS Retrospective, mu...
Source
#1Andrea Chiricozzi (UCSC: Catholic University of the Sacred Heart)H-Index: 27
#2Marina Talamonti (Sapienza University of Rome)H-Index: 15
Last. Ketty Peris (UCSC: Catholic University of the Sacred Heart)H-Index: 59
view all 42 authors...
2 CitationsSource
#1Fabrizio Guarneri (UNIME: University of Messina)H-Index: 21
#2Monica Corazza (University of Ferrara)H-Index: 28
Last. Viviana Piras (University of Cagliari)H-Index: 2
view all 15 authors...
BACKGROUND Based on the facts that Myroxylon pereirae (MP), or Balsam of Peru, is nowadays almost not used "as such", and fragrance mix 1 (FM1) apparently is more sensitive in detecting fragrance allergy, the usefulness of testing MP in baseline series was recently questioned. OBJECTIVES Identification of the number of clinically relevant patch test reactions to MP not detected by FM1. METHODS Retrospective analysis of 12 030 patients patch tested with MP and FM1 for contact dermatitis between J...
Source
#1Luca Stingeni (University of Perugia)H-Index: 19
#2Rossella Marietti (University of Perugia)H-Index: 3
Last. Katharina Hansel (University of Perugia)H-Index: 13
view all 21 authors...
BACKGROUND Budesonide was included in the European Baseline Series in 2000 as the most suitable marker for CS hypersensitivity. In the last 2 decades a decreasing trend of budesonide allergy was observed. OBJECTIVES To estimate the prevalence of positive patch test reactions to budesonide in an Italian large patch test population characterizing patients according to MOAHLFA index and evaluating the benefit with extended readings of budesonide patch test. METHODS/PATIENTS Retrospective analysis o...
1 CitationsSource
#1Nicola Milanesi (UniFI: University of Florence)H-Index: 6
#2Massimo Gola (UniFI: University of Florence)H-Index: 13
Last. Stefano Francalanci (UniFI: University of Florence)H-Index: 12
view all 3 authors...
Source
#1Andrea ChiricozziH-Index: 27
#2Marina TalamontiH-Index: 15
Last. Maria Teresa RossiH-Index: 8
view all 42 authors...
Background: Few and small studies have described the management of immunomodulant/immunosuppressive therapies or phototherapy in atopic dermatitis (AD) patients during coronavirus disease 2019 (COVID-19) pandemic. Methods: A national registry, named DA-COVID-19 and involving 35 Italian dermatology units, was established in order to evaluate the impact of COVID-19 pandemic on the management of adult AD patients treated with systemic immunomodulant/immunosuppressive medications or phototherapy. De...
Source
#1Filomena Russo (UniFI: University of Florence)H-Index: 2
#1Filomena Russo (UniFI: University of Florence)H-Index: 1
Last. Maria Laura FloriH-Index: 10
view all 12 authors...
BACKGROUND Atopic dermatitis (AD) in the elderly has been poorly investigated, although its incidence is gradually increasing mainly in industrialized countries. Age-specific factors in older patients must be considered when selecting treatment options. OBJECTIVES To evaluate the efficacy and tolerability of dupilumab in treating elderly patients with severe AD. METHODS This was a retrospective, multicenter study involving 26 elderly patients (age, ≥65 years) with severe AD who were treated with...
Source
#1Andrea ChiricozziH-Index: 27
#2Marina TalamontiH-Index: 15
Last. Maria Teresa RossiH-Index: 8
view all 41 authors...
Background: Few and small studies have described the management of immunomodulant/immunosuppressive therapies or phototherapy in atopic dermatitis (AD) patients during coronavirus disease 2019 (COVID-19) pandemic. Methods: A national registry, named DA-COVID-19 and involving 35 Italian dermatology units, was established in order to evaluate the impact of COVID-19 pandemic on the management of adult AD patients treated with systemic immunomodulant/immunosuppressive medications or phototherapy. De...
Source
#1Filomena Russo (UniFI: University of Florence)H-Index: 2
#1Filomena Russo (UniFI: University of Florence)H-Index: 1
Last. Nicola MilanesiH-Index: 6
view all 4 authors...
1 CitationsSource
#1Caterina Foti (University of Bari)H-Index: 25
#2Paolo Romita (University of Bari)H-Index: 10
Last. Fabrizio Guarneri (UNIME: University of Messina)H-Index: 21
view all 15 authors...
1 CitationsSource